Bio-Connect
ICC/IF analysis of HeLa cells transfected with (A) Tau and (B) Tau + Fyn uaing Tau (phospho Tyr18) antibody at a dilution of 1:200.
ICC/IF analysis of HeLa cells transfected with (A) Tau and (B) Tau + Fyn uaing Tau (phospho Tyr18) antibody at a dilution of 1:200.
ICC/IF analysis of HeLa cells transfected with (A) Tau and (B) Tau + Fyn uaing Tau (phospho Tyr18) antibody at a dilution of 1:200.

Tau (phospho Tyr18) antibody [9G3]

GTX54658
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetMAPT
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Tau (phospho Tyr18) antibody [9G3]
  • Delivery Days Customer
    9
  • Application Supplier Note
    IF: 1:2000 - 1:5000. IHC: 1:1000 - 1:5000. WB: 1:1000 - 1:5000
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    9G3
  • Conjugate
    Unconjugated
  • Gene ID4137
  • Target name
    MAPT
  • Target description
    microtubule associated protein tau
  • Target synonyms
    DDPAC; FTDP-17; G protein beta1/gamma2 subunit-interacting factor 1; MAPTL; microtubule-associated protein tau; MSTD; MTBT1; MTBT2; neurofibrillary tangle protein; paired helical filament-tau; PHF-tau; PPND; PPP1R103; protein phosphatase 1, regulatory subunit 103; TAU; tau-40
  • Host
    Mouse
  • Isotype
    IgG2a
  • Protein IDP10636
  • Protein Name
    Microtubule-associated protein tau
  • Scientific Description
    This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimers disease, Picks disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Fyn nanoclustering requires switching to an open conformation and is enhanced by FTLD-Tau biomolecular condensates.
    Read more
  • Vascular smooth muscle cell dysfunction contribute to neuroinflammation and Tau hyperphosphorylation in Alzheimer disease. Aguilar-Pineda JA et al., 2021 Sep 24, iScience
    Read more
  • Chromatin accessibility mapping of the striatum identifies tyrosine kinase FYN as a therapeutic target for heroin use disorder. Egervari G et al., 2020 Sep 14, Nat Commun
    Read more